Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Sramek

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Alzheimer Disease and Associated Disorders|January 1, 1995
Orthostasis in Alzheimer disease: a retrospective analysisS S Jhee, J J Sramek, T S Wardle, et al.
The Annals of Pharmacotherapy|September 1, 1996
Placebo response in anxiety disordersM A Piercy, J J Sramek, N M Kurtz, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1992
Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's diseaseN R Cutler, J J Sramek, M F Murphy, et al.
American Journal of Hypertension|December 1, 1993
Compliance in hypertension: daily v twice dailyJ J Sramek, N R Cutler, R D Seifert, et al.
The Journal of Clinical Psychiatry|June 1, 1986
Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective studyJ J Sramek, G M Simpson, R L Morrison, et al.
Depression and Anxiety|June 5, 1999
Meta-analysis of the safety and tolerability of two dose regimens of buspirone in patients with persistent anxietyJ J Sramek, W W Hong, S Hamid, et al.
Anxiety|January 1, 1994
Single-site findings in a study of the safety and efficacy of a CCKB receptor antagonist, CI-988, in the treatment of generalized anxiety disorderJ J Sramek, J F Costa, J B Adams, et al.
Life Sciences|March 6, 1998
A bridging study of LU 25-109 in patients with probable Alzheimer's diseaseJ J Sramek, M Forrest, H Mengel, et al.
The Annals of Pharmacotherapy|April 1, 1992
Detection of benzodiazepines in human hair by radioimmunoassayJ J Sramek, W A Baumgartner, T N Ahrens, et al.
Psychopharmacology Bulletin|January 1, 1993
The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trialN R Cutler, J J Sramek, T S Wardle, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Alzheimer Disease and Associated Disorders|January 1, 1995
Orthostasis in Alzheimer disease: a retrospective analysisS S Jhee, J J Sramek, T S Wardle, et al.
The Annals of Pharmacotherapy|September 1, 1996
Placebo response in anxiety disordersM A Piercy, J J Sramek, N M Kurtz, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1992
Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's diseaseN R Cutler, J J Sramek, M F Murphy, et al.
American Journal of Hypertension|December 1, 1993
Compliance in hypertension: daily v twice dailyJ J Sramek, N R Cutler, R D Seifert, et al.
The Journal of Clinical Psychiatry|June 1, 1986
Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective studyJ J Sramek, G M Simpson, R L Morrison, et al.
Depression and Anxiety|June 5, 1999
Meta-analysis of the safety and tolerability of two dose regimens of buspirone in patients with persistent anxietyJ J Sramek, W W Hong, S Hamid, et al.
Anxiety|January 1, 1994
Single-site findings in a study of the safety and efficacy of a CCKB receptor antagonist, CI-988, in the treatment of generalized anxiety disorderJ J Sramek, J F Costa, J B Adams, et al.
Life Sciences|March 6, 1998
A bridging study of LU 25-109 in patients with probable Alzheimer's diseaseJ J Sramek, M Forrest, H Mengel, et al.
The Annals of Pharmacotherapy|April 1, 1992
Detection of benzodiazepines in human hair by radioimmunoassayJ J Sramek, W A Baumgartner, T N Ahrens, et al.
Psychopharmacology Bulletin|January 1, 1993
The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trialN R Cutler, J J Sramek, T S Wardle, et al.
Pageof 11